Angiodynamics (ANGO) Assets Average (2011 - 2026)
Angiodynamics' (ANGO) quarterly Assets Average came in at $263.9 million in Q2 2026, down 6.67% on a YoY basis from $282.8 million in Q2 2025, and little changed quarter-over-quarter from $265.2 million in Q1 2026.
Analysis
Angiodynamics (ANGO) Assets Average (2011 - 2026) Analysis & Trends
Angiodynamics (ANGO) has reported Assets Average for 16 consecutive years, with $263.9 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Assets Average fell 6.67% year-over-year to $263.9 million; the trailing twelve-month figure through May 2026 stood at $263.9 million (down 6.67% YoY), and the FY2026 full-year result was $273.7 million, down 8.45% from the prior year.
- Assets Average held at $263.9 million in Q2 2026 per ANGO's latest filing, from $265.2 million in the prior quarter.
- Across five years, Assets Average topped out at $558.0 million in Q4 2022 and bottomed at $263.9 million in Q2 2026.
- Historically, Assets Average has averaged $404.5 million across 5 years, with a median of $366.7 million in 2024.
- The sharpest annual moves came in 2022 and 2024: Assets Average increased 0.54% in 2022, then sank 41.1% in 2024.
- Over 5 years, Assets Average stood at $558.0 million in 2022, then retreated by 10.96% to $496.8 million in 2023, then tumbled by 41.1% to $292.6 million in 2024, then slipped by 8.53% to $267.7 million in 2025, then fell by 1.4% to $263.9 million in 2026.
- According to Business Quant data, Assets Average over the past three periods registered $263.9 million, $265.2 million, and $267.7 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 179.79 Bn | 174.18 Bn | 7.27 Bn | 109.82 Bn |
| 2 | Intuitive Surgical | 127.69 Bn | 122.47 Bn | 1.96 Bn | 20.49 Bn |
| 3 | Medtronic | 117.23 Bn | 108.41 Bn | 6.34 Bn | 93.17 Bn |
| 4 | Stryker | 103.55 Bn | 100.07 Bn | 4.50 Bn | 47.11 Bn |
| 5 | Boston Scientific | 63.24 Bn | 62.70 Bn | 3.85 Bn | 44.78 Bn |
| 6 | Edwards Lifesciences | 49.97 Bn | 45.72 Bn | 1.35 Bn | 13.59 Bn |
| 7 | Alcon | 32.83 Bn | 31.37 Bn | 1.68 Bn | 31.36 Bn |
| 8 | Dexcom | 32.30 Bn | 30.35 Bn | 830.00 Mn | 6.54 Bn |
| 9 | Steris | 20.73 Bn | 20.25 Bn | 684.20 Mn | 10.74 Bn |
| 10 | Angiodynamics | 633.27 Mn | 579.41 Mn | 46.77 Mn | 263.92 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| May 31, 2026 | 263.92 Mn |
| Feb 28, 2026 | 265.18 Mn |
| Nov 30, 2025 | 267.66 Mn |
| Aug 31, 2025 | 272.89 Mn |
| May 31, 2025 | 282.78 Mn |
| Feb 28, 2025 | 288.51 Mn |
| Nov 30, 2024 | 292.61 Mn |
| Aug 31, 2024 | 305.65 Mn |
| May 31, 2024 | 321.26 Mn |
| Feb 29, 2024 | 412.23 Mn |
| Nov 30, 2023 | 496.79 Mn |
| Aug 31, 2023 | 513.29 Mn |
| May 31, 2023 | 537.74 Mn |
| Feb 28, 2023 | 550.53 Mn |
| Nov 30, 2022 | 557.95 Mn |
| Aug 31, 2022 | 555.23 Mn |
| May 31, 2022 | 547.96 Mn |
| Feb 28, 2022 | 548.64 Mn |
| Nov 30, 2021 | 554.93 Mn |
| Aug 31, 2021 | 558.60 Mn |